Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-JH12 PET/CT Dosimetry and Biodistribution in Cancer
NCT06688188Phase 1Recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Nov 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-JH12 in solid tumor, sponsored by The First Hospital of Fujian Medical University. Primary endpoint: Safety and tolerability at 1 week. Started Nov 2024; status: recruiting.
02
Drugs
68Ga-JH12
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06688188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06688188.